0FU73KZ
Supplement Hepatic Duct, Common to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | U Supplement |
| Body Part | 7 Hepatic Duct, Common |
| Approach | 3 Percutaneous |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment hepatobiliary or pancreatic tissue that's still in place, rather than replacing or repairing it outright. Examples include applying mesh or a biologic patch to reinforce a fragile area of liver capsule after a partial excision, or buttressing a pancreatic anastomosis with additional material to reduce the risk of a postoperative leak.
Surgeons turn to these techniques when native tissue is structurally weak, at risk of failure, or benefits from added support to hold a repair together, particularly around suture lines and areas prone to leakage of bile or pancreatic fluid. This differs from simply repairing a defect because material beyond the patient's own tissue is deliberately introduced to strengthen the area going forward.
Anatomy & Axis Detail
Hepatic Duct, Common
The common hepatic duct, situated at the convergence of the right and left hepatic ducts and running through the hepatoduodenal ligament, may require supplementation when its wall is weakened by partial injury, a repaired stricture, or thinning from chronic inflammation, without the duct being severed or removed. A patch of autologous tissue, such as a jejunal or gallbladder serosal graft, or biologic material is applied to reinforce the ductal wall and preserve native bile flow through the duct rather than diverting it through a bypass. This is generally favored when the duct's overall continuity and caliber remain adequate, avoiding the added complexity of Roux-en-Y reconstruction required after full resection. Supplement coding applies specifically when reinforcing material augments the existing duct wall rather than replacing the ductal segment outright.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders should look for explicit mention of a graft, mesh, or biologic patch placed to reinforce or bolster existing tissue, since Supplement requires that the underlying body part remains and is only being strengthened. The material used and its placement site should be documented clearly enough to assign the correct device character. A recurring error is coding Supplement when the material actually substituted for excised tissue rather than reinforcing tissue left behind, which belongs under Replacement instead, so coders need to confirm whether any of the original structure was removed.